Extra-adrenal Pheochromocytoma in the Organ of Zuckerkandl: Diagnosis and Treatment Strategies

Abstract

Pheochromocytoma (PHEO) and paraganglioma (PGL) are rare catecholamine-secreting neuroendocrine tumors arising from chromaffin tissue and can occur within the adrenal medulla (PHEO) or extra-adrenal sites (PGL). The most common site for PGL is the organ of Zuckerkandl, extra-adrenal chromaffin tissue near the origin of the inferior mesenteric artery.We here present 2 patients with extra-adrenal PGL in the organ of Zuckerkandl, located by iodine-123-metaiodobenzylguanadine (¹²³I-MIBG) scintigraphy and thereafter treated surgically or with iodine-131-metaiodobenzylguanadine (¹³¹I-MIBG). First, in a 15-year-old boy with clinical suspicion of PHEO, the diagnosis was established by biochemical evaluation and confirmed by further imaging studies, including CT and ¹²³I-MIBG, as PGL in the Zuckerkandl organ. The tumor was completely resected by laparotomy. Second, in a 70-year-old woman presenting with progressive hypertension and palpitations, MR and ¹²³I-MIBG revealed a singular tumor lesion with abnormal ¹²³I-MIBG uptake in the Zuckerkandl organ. Due to severe general vascular disease, surgery was not performed and instead the patient underwent ¹³¹I-MIBG therapy. The patient showed a good symptomatic response with improvement of symptoms and no relevant side-effects of therapy.

extra-adrenal Pheochromocytoma - iodine-123-metaiodobenzylguanadine (¹²³I-MIBG) - iodine-131-metaiodobenzylguanadine (¹³¹I-MIBG)

References

• 1 Adler JT, Meyer-Rochow GY, Chen H. et al . Pheochromocytoma: current approaches and future directions.  Oncologist. 2008;  13 779-793
• 2 Armstrong R, Sridhar M, Greenhalgh KL. et al . Phaeochromocytoma in children.  Arch Dis Child. 2008;  93 899-904
• 3 Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population.  Ann NY Acad Sci. 2006;  1073 30-37
• 4 Chrisoulidou A, Kaltsas G, Ilias I. et al . The diagnosis and management of malignant phaeochromocytoma and paraganglioma.  Endocr Relat Cancer. 2007;  14 569-585
• 5 Fottner C, Helisch A, Anlauf M. et al . 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.  J Clin Endocrinol Metab. 2010;  95 2800-2810
• 6 Frankel F. Classics in oncology. A case of bilateral completely latent adrenal tumor and concurrent nephritis with changes in the circulatory system and retinitis: Felix Frankel, 1886.  CA Cancer J Clin. 1984;  34 93-106
• 7 Giammarile F, Chiti A, Lassmann M. et al . EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.  Eur J Nucl Med Mol Imaging. 2008;  35 1039-1047
• 8 Greenblatt DY, Shenker Y, Chen H. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma.  Ann Surg Oncol. 2008;  15 900-905
• 9 Grunwald F, Ezziddin S. 131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors.  Semin Nucl Med. 2010;  40 153-163
• 10 Ishibashi N, Abe K, Furuhashi S. et al . Adverse allergic reaction to 131I MIBG.  Ann Nucl Med. 2009;  23 697-699
• 11 Jacobson AF, Deng H, Lombard J. et al . 123I-Meta-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis.  J Clin Endocrinol Metab. 2010; 
• 12 Lenders JW, Eisenhofer G, Mannelli M. et al . Phaeochromocytoma.  Lancet. 2005;  366 665-675
• 13 Lumachi F, Tregnaghi A, Zucchetta P. et al . Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study.  Nucl Med Commun. 2006;  27 583-587
• 14 Luster M, Karges W, Zeich K. et al . Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.  Eur J Nucl Med Mol Imaging. 2010;  37 484-493
• 15 Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges.  Ann NY Acad Sci. 2006;  1073 1-20
• 16 Manger WM. The vagaries of pheochromocytomas.  Am J Hypertens. 2005;  18 1266-1270
• 17 Manger WM, Gifford Jr RW, Hoffman BB. Pheochromocytoma: a clinical and experimental overview.  Curr Probl Cancer. 1985;  9 1-89
• 18 Mannelli M, Ianni L, Cilotti A. et al . Pheochromocytoma in Italy: a multicentric retrospective study.  Eur J Endocrinol. 1999;  141 619-624
• 19 Maurea S, Cuocolo A, Reynolds JC. et al . Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.  J Nucl Med. 1993;  34 173-179
• 20 Nakabeppu Y, Nakajo M. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.  Ann Nucl Med. 1994;  8 259-268
• 21 Petri BJ, van Eijck CH, de Herder WW. et al . Phaeochromocytomas and sympathetic paragangliomas.  Br J Surg. 2009;  96 1381-1392
• 22 Shulkin BL, Ilias I, Sisson JC. et al . Current trends in functional imaging of pheochromocytomas and paragangliomas.  Ann NY Acad Sci. 2006;  1073 374-382
• 23 Van Der Horst-Schrivers AN, Jager PL, Boezen HM. et al . Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas – experience and meta-analysis.  Anticancer Res. 2006;  26 1599-1604
• 24 Waguespack SG, Rich T, Grubbs E. et al . A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.  J Clin Endocrinol Metab. 2010;  95 2023-2037
• 25 Wyszynska T, Cichocka E, Wieteska-Klimczak A. et al . A single pediatric center experience with 1025 children with hypertension.  Acta Paediatr. 1992;  81 244-246
• 26 Zuckerkandl E. Ueber Nebenorgane des Sympathicus im Retroperitonealraum des Menschen.  Verhandl Anat Ges. 1901;  15 85-107

Correspondence